OPTIMARK IN PLASTIC CONTAINER

LOE Approaching

gadoversetamide

NDAINJECTIONINJECTABLE
Approved
Dec 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT01092754Phase 4Completed

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients

Started May 2002
100 enrolled
Pathological Processes